Earnings Call Transcripts

Access detailed transcripts and key takeaways from company earnings calls

All Earnings Calls

OSIS May 4, 2026

OSI Systems Q3 Fiscal 2026 Earnings Call - Record Backlog Hits $1.9B as Mexico Headwinds Fade

OSI Systems delivered a record fiscal Q3 with revenues of $453 million and non-GAAP EPS of $2.60, setting a new high for the quarter. The company’s backlog surged to a record $1.9 billion, driven by s...

  • Record Q3 revenues of $453 million and non-GAAP EPS of $2.60, both quarter highs.
  • Backlog reached a record $1.9 billion, providing multi-period visibility.
  • Security revenues grew 25% year-over-year excluding Mexico contracts, which declined significantly.
  • +7 more takeaways
MED May 4, 2026

Medifast Q1 2026 Earnings Call - First Sequential Revenue Growth in 3 Years Signals Metabolic Pivot Gaining Traction

Medifast reported a 34.3% year-over-year revenue decline to $76.0 million in Q1 2026, driven by a 44.9% drop in active earning coaches amid GLP-1 disruption. However, the company delivered its first s...

  • Q1 2026 revenue fell 34.3% year-over-year to $76.0 million, primarily due to a 44.9% decline in active earning coaches.
  • Coach productivity surged 19.2% year-over-year and 16% sequentially, marking the largest quarterly gains in five and eight years, respectively.
  • The company achieved its first sequential revenue growth in three years, signaling a potential inflection point after years of contraction.
  • +7 more takeaways
RBA May 4, 2026

RB Global Q1 2026 Earnings Call - Raised 2026 Guidance on Strong GTV Growth and Margin Expansion

RB Global delivered a strong first quarter in 2026, with adjusted EBITDA up 11% and gross transaction value (GTV) rising 13% to $4.3 billion. The company raised its full-year 2026 guidance, citing rob...

  • Adjusted EBITDA grew 11% year-over-year, outpacing service revenue growth of 5% and demonstrating strong operating leverage.
  • Gross transaction value (GTV) increased 13% to $4.3 billion, driven by 27% growth in commercial construction and transportation and 7% growth in automotive.
  • Management raised full-year 2026 guidance, now expecting GTV growth of 6-9% and adjusted EBITDA growth of approximately 8% at the midpoint.
  • +7 more takeaways
EVER May 4, 2026

EverQuote Q1 2026 Earnings Call - Record EBITDA and Agentic AI Push

EverQuote delivered a standout first quarter, crushing guidance with 15% revenue growth to $190.9 million and a 30% surge in Adjusted EBITDA to a record $29.3 million. The company is capitalizing on a...

  • Revenue grew 15% year-over-year to $190.9 million, beating the high end of guidance.
  • Adjusted EBITDA surged 30% to a record $29.3 million, marking the third consecutive quarter with annualized Adjusted EBITDA at or above $100 million.
  • Carriers have shifted into aggressive growth mode, with 80% of the top 25 carriers now below peak quarterly spend, driving increased demand for EverQuote’s digital channels.
  • +7 more takeaways
MATX May 4, 2026

Matson, Inc. Q1 2026 Earnings Call - Full-Year Outlook Raised on China Demand Surge

Matson reported a $20.7 million year-over-year drop in Q1 2026 operating income to $61.4 million, weighed down by softer Hawaii and Alaska volumes and a dip in logistics margins. Yet the real story is...

  • Q1 2026 consolidated operating income fell $20.7 million year-over-year to $61.4 million, driven by lower ocean transportation and logistics contributions.
  • China service volumes dropped 9.5% year-over-year in Q1 due to a traditional Lunar New Year slowdown, but post-holiday demand surged beyond expectations.
  • Management raised its full-year consolidated operating income outlook, now expecting it to modestly exceed 2025 levels, citing sustained China trade strength through peak season.
  • +7 more takeaways
ICHR May 4, 2026

Ichor Holdings Q1 2026 Earnings Call - Unconstrained Demand Surges Past $300M as Margin Expansion Accelerates

Ichor Holdings delivered a blistering start to 2026, with Q1 revenues hitting $256 million and gross margins expanding to 12.8%. The company is now guiding Q2 revenues to approximately $300 million, r...

  • Q1 2026 revenues reached $256 million, up 15% sequentially, landing at the upper end of guidance and signaling strong demand momentum.
  • Gross margins expanded to 12.8%, up 110 basis points sequentially, driven by factory leverage and the early benefits of the global footprint realignment.
  • Operating income more than tripled to $8.7 million, marking the highest earnings per share in three years and demonstrating significant operating leverage.
  • +7 more takeaways
BDSX May 4, 2026

Biodesix Q1 2026 Earnings Call - Revenue Jumps 42% as Primary Care Expansion Drives Test Volume Growth

Biodesix delivered a forceful start to 2026, with Q1 revenue surging 42% year-over-year to $25.6 million. The growth was not a fluke. It was powered by a 29% jump in test volumes, fueled by a delibera...

  • Total revenue surged 42% year-over-year to $25.6 million, beating expectations and driven by strong commercial execution.
  • Diagnostic testing revenue grew 37% to $22.3 million, supported by a 29% increase in test volumes to approximately 17,800 tests.
  • Primary care adoption is accelerating, now representing 15% of total test volumes, validating the company's strategic shift into this channel.
  • +7 more takeaways
NSPR May 4, 2026

InspireMD Q1 2026 Earnings Call - U.S. CGuard Prime Recall Forces Revenue Guidance Withdrawal

InspireMD reported a strong first quarter with revenue of $3.4 million, up 122% year-over-year, driven by the U.S. launch of CGuard Prime and robust international growth. However, the company voluntar...

  • Q1 2026 revenue reached $3.4 million, a 122% increase year-over-year, fueled by the U.S. launch of CGuard Prime and strong international expansion.
  • InspireMD voluntarily paused U.S. commercialization of the CGuard Prime 135 delivery system following FDA feedback on technical performance, though the stent implant itself remains clinically excellent.
  • The company withdrew its full-year 2026 revenue guidance to reflect the temporary U.S. commercial pause and the timeline for FDA approval of the legacy CGuard delivery system.
  • +7 more takeaways
GAIA May 4, 2026

Gaia Q1 2026 Earnings Call - Executing a Deliberate Pivot to Direct Memberships

Gaia is actively restructuring its growth engine by shifting focus from third-party subscription platforms to a high-value direct membership model. Chairman Jirka Rysavy and CEO Kiersten Medvedich out...

  • Strategic Pivot to Direct Memberships: Gaia is deliberately shifting away from third-party subscription platforms, which historically generated lower ARPU, higher churn, and no direct member data, toward a high-value direct membership model to capture greater lifetime value and brand control.
  • Pricing Discipline Implemented: A 15% price increase was rolled out across approximately 80% of regions for monthly members in March, with annual member increases taking effect at renewal, aimed at boosting ARPU by 20%-25% by Q4 2026.
  • Near-Term Revenue Lull Expected: Management anticipates a temporary slowdown in top-line growth over the next one to two quarters as the company reduces reliance on third-party channels, tightens discounting, and rebuilds its direct marketing infrastructure.
  • +7 more takeaways
VLO May 4, 2026

Valero Energy Q1 2026 Earnings Call - Record Margins Amid Global Supply Shock and Port Arthur Disruption

Valero Energy delivered a blockbuster first quarter of 2026, posting $1.3 billion in net income and $4.22 per share, a stark reversal from the prior year's loss. The result underscores the company's s...

  • Valero reported $1.3 billion in net income, or $4.22 per share, for Q1 2026, a massive turnaround from a $595 million net loss in the prior-year quarter.
  • Refining segment operating income surged to $1.8 billion, compared to an operating loss of $530 million in Q1 2025.
  • Shareholder returns totaled $938 million in Q1, including a 6% dividend increase to $1.07 per share, resulting in a 59% payout ratio.
  • +7 more takeaways